Stelios Papadopoulos, Director at Exelixis, holds 1.19M shares in Exelixis (Ticker: EXEL), holds 0.00 shares in Regulus (Ticker: RGLS), holds 38.30K shares in Biogen (Ticker: BIIB). Most recently, Stelios Papadopoulos Sold ― shares of Exelixis on Nov 13, 2025 for an estimated value of $4.36M.
What was Stelios Papadopoulos’s latest transaction?
Stelios Papadopoulos latest transaction was an Informative Sell of $4.36M.
What was Stelios Papadopoulos's most profitable transaction?
Stelios Papadopoulos’s most profitable transaction was an Informative Sell of EXEL stock on September 20, 2017. The return on the trade was 40.20%.
What is Stelios Papadopoulos's role in Exelixis?
Stelios Papadopoulos's role in Exelixis is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.